Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...
Samsung states many older devices will miss out on a "deeper AI experience" due to hardware limitations. This echoes what happened with Galaxy AI as some phones saw very few features arrive in 2024.
By combining advanced manufacturing capabilities with cutting-edge science and clinical development capabilities, AdvanCell aims to deliver novel treatments that improve outcomes for cancer patients ...